Synedgen is a bio-pharmaceutical company committed to developing novel therapies and products to save lives – in hospitals, on the battlefield, in our food supply and in the home. Synedgen was formed in 2009 through the merger of BioSTAR West LLC (Claremont, CA) and Hawaii Chitopure Inc. (Honolulu, HI). BioSTAR West was founded in 2005 to generate research and development expertise in biopolymer processing and polymer interactions with mammalian cells and bacteria. This research led to chemical modifications of a natural biopolymer and examination of the molecular interactions of these derivatives with tissue and bacterial pathogens. Hawaii Chitopure, which was founded in 2004 to develop a domestic source of ultra-pure chitosan with funding support from the U.S. Army, established a GMP-ready manufacturing facility in Hawaii to produce medical grade chitosan and chitosan derivatives.